Medico Remedies Limited has informed the Exchange regarding Resignation of Dayanand Mathapati as Executive Director of the company w.e.f. April 09, 2025.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medico Remedies Limited has informed the stock exchange that Dayanand Mathapati has resigned from the post of Executive Director of the company, effective April 9, 2025. The announcement does not mention the reason for the resignation or who will take over the responsibilities. No other board changes or appointment details have been shared in this filing. Shareholders would need to watch for further updates from the company on succession plans.
An Executive Director resignation can create short-term uncertainty around leadership and decision-making at the company, especially for smaller firms. The stock may see mild negative sentiment unless a strong replacement is announced quickly.